Impact of GLP-1 Receptor Agonists on Major Gastrointestinal Disorders for Type 2 Diabetes Mellitus: A Mixed Treatment Comparison Meta-Analysis

Aim. We aimed to integrate evidence from all randomized controlled trials (RCTs) and assess the impact of different doses of exenatide or liraglutide on major gastrointestinal adverse events (GIAEs) in type 2 diabetes (T2DM). Methods. RCTs evaluating different doses of exenatide and liraglutide agai...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sun, Feng, Yu, Kai, Yang, Zhirong, Wu, Shanshan, Zhang, Yuan, Shi, Luwen, Ji, Linong, Zhan, Siyan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2012
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3540917/
https://ncbi.nlm.nih.gov/pubmed/23365557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/230624
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi